Vista Pharmaceuticals share news, announcements and annual reports

BSE: 524711Pharmaceuticals & BiotechnologySmall Cap

Vista Pharmaceuticals Ltd. · Face value ₹2 · Listed Dec 1994

₹6.21₹0.24 (3.72%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹6.45.

30 Oct: open ₹6.50, high ₹6.50, low ₹6.15

52-week range of traded prices to 30 Oct 2026

₹5.32Low, 16 Sep 2026₹10.29High, 30 Oct 2025

Market cap: ₹38 Cr3,508th largest listed
P/E: Lossover the last 12 months
P/B: 1.05
Dividend yield: Nonein the last 12 months
ROE: −28.7%
ROCE: −32.5%
Debt to equity: 0.27
Volume, BSE: 2,884

Vista Pharmaceuticals share news and announcements

532 announcements, routine notices left out, newest first. Page 3 of 11.

Jul 2023
- 18 Jul · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the allotment of 23,32,625 equity shares on conversion of 23,32,625 warrants to others on a preferential Basis
- 13 Jul · Announcement under Regulation 30 (LODR)-Allotment
  Announcement of Outcome of Board Meeting pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ....
Jun 2023
- 30 Jun · Announcement under Regulation 30 (LODR)-Allotment
  Allotment of 3,33,333 Equity Shares on conversion of 3,33,333 warrants to the other on preferential basis
- 16 Jun · Management
  ["Listing Regulations"), we hereby inform that ....
- 9 Jun · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 1 Jun · Business
  Read with SEBI Circular CIR/CFD/CMD1/16212019 dated December 24, 2019 please find ....
May 2023
- 30 May · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Tuesday, 30.05.2023 at 04.00 P.M at the registered address of ....
- 30 May · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Tuesday, 30.05.2023 at 04.00 P.M and ended at 10.00 P.M at ....
- 27 May · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 25 May · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 23 May · Board meeting
  Meeting on 30 May 2023: audited results
- 23 May · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve With reference to the ....
- 8 May · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
Apr 2023
- 29 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Reg
  We hereby submit the Compliance Certificate certifying that we are maintaining all ....
- 24 Apr · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 15 Apr · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  With reference to the subject matter cited and pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith certificate ....
- 10 Apr · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
  We would like to inform you that consequent to the Resolution by Circulation passed by the Board of Diretors of the Company, ....
- 10 Apr · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 1 Apr · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
Mar 2023
- 28 Mar · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- ....
- 17 Mar · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2O22 and lnprinciple ....
- 9 Mar · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2O22 and ln-principle ....
Feb 2023
- 13 Feb · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Monday, 13.02.2023 at 04.00 P.M at the corporate office of the ....
- 13 Feb · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 13.02.2023 at 04.00 P.M and ended at 05.50 P.M at the ....
- 7 Feb · Board meeting
  Meeting on 13 Feb 2023: quarterly results
- 7 Feb · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve With reference to the ....
Dec 2022
- 23 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamal Gadalay & PACs
- 23 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh Gadaley & PACs
- 14 Dec · Announcement under Regulation 30 (LODR)-Allotment
  This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and lnprinciple ....
Nov 2022
- 16 Nov · Board meeting
  Revised outcome With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 14th November, 2022 at 01:00 PM and ....
- 15 Nov · Results
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Monday, 14th November, 2022 at 01.00 P.M. at the corporate ....
- 14 Nov · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 14th November, 2022 at 01:00 PM, at the corporate office ....
- 14 Nov · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 14th November, 2022 at 01:00 PM, at the corporate office ....
- 9 Nov · Board meeting
  Meeting on 14 Nov 2022: quarterly results
- 8 Nov · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve With reference to the ....
Oct 2022
- 20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 20 Oct · Board meeting
  With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on 20th October, 2022 at 11.00 AM, at the corporate office of the ....
- 14 Oct · Results
  We write to inform you that the members of the Company have approved all the resolutions ....
- 14 Oct · Meeting
  With reference to the above subject citied, the (1st of 2022-23) Extra Ordinary General Meeting (EGM) of the Members of Vista Pharmaceuticals Limited ('the Company') was held on Friday, ....
- 13 Oct · Meeting
  With reference to the subject cited, please find enclosed a corrigendum to the notice convening 1st of 2022-23) Extra ordinary General Meeting (EGM) of the Company to be held on Friday, ....
Sep 2022
- 29 Sep · Meeting
  We write to inform you that the members of the Company have approved all the resolutions ....
- 29 Sep · Meeting
  Subject: Summary of Outcome/Proceedings - 31st Annual General Meeting of the Company held on Thursday, 29th September, 2022 at 03.30 P.M. through Video Conferencing (VC) / Other Audio-Visual ....
- 21 Sep · Meeting
  This is to inform the exchange that pursuant to Section 100 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure ....
- 19 Sep · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  With reference to the subject matter cited and pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith certificate ....
- 19 Sep · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March, 2022
  We here submit the Compliance Certificate certifying that we are maintaining all ....
- 10 Sep · Management
  In reference to Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015 submitted by Company dated 08-Sep-2022 01:25:17 PM, the company hereby provides the required ....
- 8 Sep · Board meeting
  In furtherance to our intimation letter dated September 03rd, 2022 and with reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting ....
- 7 Sep · Reg. 34 (1) Annual Report.
  In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, we herewith submit the 31st Annual Report for the Financial Year 2021-2022 ....
- 7 Sep · Meeting
  This is to inform the exchange that pursuant to Section 96 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure ....
- 5 Sep · Board meeting
  Meeting on 8 Sep 2022: issue of warrants

Vista Pharmaceuticals share news and announcements

Jul 2023

Jun 2023

May 2023

Apr 2023

Mar 2023

Feb 2023

Dec 2022

Nov 2022

Oct 2022

Sep 2022